- $14.78m
- -$3.80m
- $0.65m
- 23
- 20
- 46
- 20
2019 December 31st | 2020 December 31st | 2021 December 31st | R2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 2.29 | 5.42 | 2.82 | 0 | 0.651 |
Cost of Revenue | |||||
Gross Profit | -4.52 | -0.616 | -0.935 | — | — |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 56.5 | 46.4 | 38.8 | 25.3 | 17.5 |
Operating Profit | -54.2 | -41 | -36 | -25.3 | -16.9 |
Total Net Non Operating Interest Income / Expense | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -53.2 | -40.4 | -35.1 | 59.1 | -10.3 |
Provision for Income Taxes | |||||
Net Income After Taxes | -53.2 | -40.4 | -35.1 | 59.1 | -10.3 |
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | -53.2 | -40.4 | -35.1 | 47.8 | -18.4 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -53.2 | -40.4 | -35.1 | 42.3 | -18.4 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -13.4 | -9.47 | -5.88 | 7.92 | -0.721 |